Log In
Print this Print this

Tafinlar, dabrafenib (GSK2118436)

Also known as: 2118436

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionOral BRAF protein kinase inhibitor
Molecular Target BRAF
Mechanism of ActionBRAF inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today